Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity
Tick-borne encephalitis virus (TBEV) causes 5−7 thousand cases of human meningitis and encephalitis annually. The neutralizing and protective antibody ch14D5 is a potential therapeutic agent. This antibody exhibits a high affinity for binding with the D3 domain of the glycoprotein E of the Far Easte...
Main Authors: | Ivan K. Baykov, Pavel Y. Desyukevich, Ekaterina E. Mikhaylova, Olga M. Kurchenko, Nina V. Tikunova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/8/1494 |
Similar Items
-
Tick-Borne Encephalitis, Lombardy, Italy
by: Alessandra Gaffuri, et al.
Published: (2024-02-01) -
Chimeric Antibody 14D5 Protects Mice against the Far-Eastern, Siberian, and European Tick-borne Encephalitis Virus
by: Andrey L. Matveev, et al.
Published: (2019-04-01) -
Effectiveness of Specific Prevention of Tick-Borne Encephalitis
by: M. S. Shcherbinina, et al.
Published: (2020-09-01) -
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report
by: Nicole Barp, et al.
Published: (2022-07-01) -
ON MODERN APPROACHES TO CREATION OF A SINGLE-CYCLE VACCINE AGAINST TICK-BORNE ENCEPHALITIS
by: V. A. Lashkevich, et al.
Published: (2018-06-01)